Raphael Scharfmann

U1016 INSERM-Institut, Cochin Groupe Hospitalier Cochin-Port-Royal, Paris, France

“Beta Cell Development: From Rodent to Human”


Óscar Fernández-Capetillo

Spanish National Cancer Research Center, Madrid, Spain

“Targeting oncogene-induced DNA damage for cancer therapy”


Lucas Pelkmans

Institute of Molecular Life Sciences, University of Zurich, Switzerland

“Cell-intrinsic adaptation of lipid composition to local crowding drives social behavior”


Kathryn Moore

Departments of Medicine and Cell Biology, NYU Langone Medical Center and School of Medicine, New York, United States

“Mechanisms of chronic inflammation in metabolic diseases”

Benjamin Cravatt

Department of Chemical Physiology, The Skaggs Institute for Chemical Biology

The Scripps Research Institute, La Jolla, CA, United States

“Activity-based proteomics – applications for enzyme and inhibitor discovery”

Christopher Glass

Cellular & Molecular Medicine, University of California San Diego, La Jolla, CA, United States

“A genome wide view of macrophage activation”


Holger Sondermann

Department of Molecular Medicine, Cornell University, Ithaca, NY, United States

“The Ins and Outs of c-di-GMP Signaling in Bacterial Biofilm Formation”


Thomas Helleday

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

“Targeting MTH1 for de-personlised anti-cancer treatment”


Janet Kelso

The Minerva Research Group for Bioinformatics, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany

“What we have learned from sequencing ancient genomes”


Thirumala-Devi Kanneganti

Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, United States

“Regulators of Inflammatory Responses”


Olli Kallioniemi

Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland

“Individually optimized cancer therapies for Acute Myeloid Leukemia and beyond”